Skip to Content

STO 50 (Carbidopa, entacapone and levodopa 12.5 mg / 200 mg / 50 mg)

Pill with imprint STO 50 is Red, Round and has been identified as Carbidopa, entacapone and levodopa 12.5 mg / 200 mg / 50 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 12.5 mg / 200 mg / 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for STO 50

Carbidopa, entacapone and levodopa

STO 50
12.5 mg / 200 mg / 50 mg
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.